Corbus Pharmaceuticals is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.
500 River Ridge Drive
Norwood, MA 02062
Institutional Investor Inquiries:
Corbus Pharmaceuticals, Inc.
Ted Jenkins, Senior Director, Investor Relations and Communications
All Other Investor Inquiries:
Jenene Thomas Communications
Scient Public Relations